Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
881 Irritable Bowel Syndrome (IBS)
clinical trials

Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Oncology and Hematology Associates-Laurel
mi
from
Des Moines, IA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Southdale Hospital
mi
from
Edina, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Carle Physician Group-Effingham
mi
from
Effingham, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Genesee Cancer & Blood Disease Treatment Center, PC
mi
from
Flint, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Western Illinois Cancer Treatment Center
mi
from
Galesburg, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Kadlec Clinic Hematology and Oncology
mi
from
Kennewick, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Kewanee Clinic
mi
from
Kewanee, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Sparrow Hospital
mi
from
Lansing, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Luke's East - Lee's Summit
mi
from
Lee's Summit, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Minimally Invasive Surgery Hospital
mi
from
Lenexa, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Hospital East
mi
from
Lexington, KY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Elizabeth Regional Medical Center
mi
from
Lincoln, NE
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Mary Mercy Hospital
mi
from
Livonia, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute - Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Newberg Medical Center
mi
from
Newberg, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Princeton
mi
from
Princeton, IL
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Mary - Corwin Medical Center
mi
from
Pueblo, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers - Pueblo
mi
from
Pueblo, CO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Sainte Genevieve County Memorial Hospital
mi
from
Sainte Genevieve, MO
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Regional Cancer System-Shelton
mi
from
Shelton, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwest Medical Specialties
mi
from
Tacoma, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers - Thornton
mi
from
Thornton, CO
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology Clinical Trial
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Trial for New Treatment of Adult Patients With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Borland-Groover Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Trial for New Treatment of Adult Patients With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Aventiv Research
mi
from
Columbus, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Trial for New Treatment of Adult Patients With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Elite Clinical Studies
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Kentucky, Markey Cancer Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Associates
mi
from
Huntsville, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
TriWest Research Associates
mi
from
La Mesa, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Treatment Invention for Children With Functional Gastrointestinal Pain
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Accord Clinical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Rockford Gastroenterology Associates, Ltd.
mi
from
Rockford, IL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Impact Clinical Trials
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Alliance Clinical Trials
mi
from
Birmingham, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Metropolitan Gastroenterology Group, PC Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Rapid Medical Research, Inc.
mi
from
Cleveland, OH
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Lovelace Scientific Resources
mi
from
Henderson, NV
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Baylor College of Medicine, Baylor Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Jackson Clinic, PA
mi
from
Jackson, TN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Medical Center for clinical research
mi
from
San Diego, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Rowan Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling, Phase II, III
Updated: 4/7/2008
Westlake Medical Research
mi
from
Westlake Village, CA
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal, Neurology, Rheumatology Clinical Trial
Observational Study of Control Participants for the MAPP Research Network
Status: Enrolling
Updated: 5/14/2013
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
Status: Enrolling, Phase
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
Status: Enrolling, Phase
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal, Neurology, Rheumatology Clinical Trial
Observational Study of Control Participants for the MAPP Research Network
Status: Enrolling
Updated: 5/14/2013
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal, Neurology, Rheumatology Clinical Trial
Observational Study of Control Participants for the MAPP Research Network
Status: Enrolling
Updated: 5/14/2013
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal, Neurology, Rheumatology Clinical Trial
Observational Study of Control Participants for the MAPP Research Network
Status: Enrolling
Updated: 5/14/2013
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
Status: Enrolling, Phase II
Updated: 9/9/2014
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Lexicon Investigational Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Lexicon Investigational Site
mi
from
Brockton, MA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Lexicon Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Lexicon Investigational Site
mi
from
Eugene, OR
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Lexicon Investigational Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Lexicon Investigational Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Lexicon Investigational Site
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Lexicon Investigational Site
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Lexicon Investigational Site
mi
from
Ogden, UT
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
Status: Enrolling, Phase III
Updated: 10/28/2015
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
Status: Enrolling, Phase III
Updated: 10/28/2015
Children's Mercy Hospitals and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
Status: Enrolling, Phase III
Updated: 10/28/2015
University of California San Francisco Benioff Children's Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Lenox Hill Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Wake Forest School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling, Phase II
Updated: 12/13/2013
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Inflammatory Bowel Diseases Clinical Trial
Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Intestinal Diseases Clinical Trial
Anti- Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease
Status: Enrolling
Updated: 8/28/2014
Ertan Digestive Disease Center at Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Inflammatory Bowel Disease (IBD) Clinical Trial
The Effect of Methotrexate on Sperm Quality in Men With Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Diarrhea Clinical Trial
Epidemiology of Diarrheal Diseases in Pediatric Oncology Patients
Status: Enrolling, Phase
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Gastroenterology, Rheumatology Clinical Trial
Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
Status: Enrolling
Updated: 12/31/1969
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 7/6/2016
Cumberland Research Associates
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 7/6/2016
Meritus Center For Clinical Research
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 7/6/2016
Nashville Medical Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 7/6/2016
Arkansas Gastroenterology
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling, Phase II
Updated: 7/6/2016
Inland Empire Liver Foundation
mi
from
Rialto, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Advanced Research Center, Inc.
mi
from
Anaheim, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Asheboro Research Associates
mi
from
Asheboro, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Boys Town National Research Hospital
mi
from
Boys Town, NE
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Childrens Hospital. Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
GI Associates and Endoscopy Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Capital Pediatrics & Adolescent Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling, Phase II
Updated: 12/31/1969
Sun Research Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
Status: Enrolling, Phase
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
Ironwood Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
Ironwood Investigational Site
mi
from
Arlington, TX
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling, Phase II
Updated: 1/12/2016
Ironwood Investigational Site
mi
from
Bastrop, LA
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9